BINYAMINA, Israel, Feb. 1, 2023 /PRNewswire/ — OncoHost, a precision diagnostics company centered on predictive biomarker development for improved patient care, today announced the official launch of its PROphet® non-small lung cancer (NSCLC) Test in the United States. Read...
Read MoremPrest teams up with Energy Queensland, one of Australia’s largest electricity distribution organizations, to provide a grid topology aware DERMS supporting Energy Queensland’s large current and expanding install-base of DERs and DER programs Read...
Read MoreLARKSPUR, Calif.–(BUSINESS WIRE)–Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of potentially best-in-class IL-2 therapeutics, today announced that the first patient has been dosed in the United States in its Phase 1/2 clinical trial evaluating AU-007 for the treatment of solid tumors. Read...
Read MoreTEL AVIV, Israel, Feb. 1, 2023 /PRNewswire/ — NT-Tao, the nuclear fusion energy company setting a new standard for the future of clean energy, today announced that it has raised a $22M Series A round led by Delek US – a Fortune 500 downstream energy company – and NextGear Ventures, with additional participation from Honda, OurCrowd and the Grantham Foundation, the lead investor in the company’s seed round. This new funding will enable NT-Tao to continue to scale its team, accelerate prototype developments in the pipeline and build its new research facility. The latest investment round brings NT-Tao’s total funding to $28M. Read more...
Read More
